PCOS and GLP-1s: Improving Reproductive Functionality For PCOS, the human evidence on GLP-1 medications is compelling enough that they now feature in the 2023 International PCOS Guidelines, though as a conditional recommendation (1)
Its a gentle, effective daily moisturizer
A huge part of what we do is we teach you to read your own effort and your Rep range goal setting Philip Pape 22:13 own data across the board, not just training, but nutrition, biofeedback, all of it, so that you stop guessing
The state Department of Health Services says it has confirmed a case of a particular variant of mpox known as Clade-1 in an Arizona resident traveling outside the U.S
Only your doctor can decide the appropriate injection schedule for you after assessing your condition and reviewing your medical history and laboratory results
Gastrointestinal effects represent the most common concern: Nausea and vomiting : May be pronounced when initiating either medication or during Wegovy dose escalation Diarrhoea or constipation : Both medications can affect bowel habits Reduced appetite : Wegovy's appetite-suppressing effects combined with SSRI-related nausea may significantly reduce food intake Abdominal discomfort : Bloating, dyspepsia, or gastric pain may occur To minimise gastrointestinal distress, consider taking escitalopram with food and following the gradual Wegovy dose escalation schedule precisely